Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/5942
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Efficacy of intra-muscular analgesics for acute pain in sheep
Author: Grant, C.
Upton, R.
Kuchel, T.
Citation: Australian Veterinary Journal, 1996; 73(4):129-132
Publisher: AUSTRALIAN VETERINARY ASSN
Issue Date: 1996
ISSN: 0005-0423
1751-0813
Abstract: The analgesic action of intramuscularly injected buprenorphine, methadone, flunixin meglumine and xylazine was examined in sheep, using algesimetry based on a leg withdrawal response to an electrical stimulus. No analgesic response was detected for buprenorphine, methadone or flunixin meglumine. Only the alpha 2-adrenoceptor agonist, xylazine, produced an analgesic response. The current required to elicit a response increased by 170% (4.5 +/- 0.43 mA to 12.23 +/- 1.14 mA; mean +/- SE) after a dose of 0.05 mg/kg xylazine; by 180% (4.73 +/- 0.3 mA to 13.28 +/- 2.35 mA) after 0.1 mg/kg and by 510% (4.52 +/- 0.29 mA to 27.63 +/- 3.89 mA) after 0.2 mg/kg. Intramuscular xylazine appears to be an effective analgesic agent for acute pain in the sheep and further investigation into ideal administration regimens and dosage may provide more detailed information on relationships between dose, analgesic and sedative effects. The findings also suggest that some common analgesic agents, and opioids in particular, may be ineffective for the management of acute pain in sheep and that any analgesic should be administered only on the basis of its proven efficacy in that species.
Keywords: Animals
Sheep
Pain
Sheep Diseases
Acute Disease
Xylazine
Analgesics
Treatment Outcome
Injections, Intramuscular
Female
Male
DOI: 10.1111/j.1751-0813.1996.tb10004.x
Published version: http://dx.doi.org/10.1111/j.1751-0813.1996.tb10004.x
Appears in Collections:Anaesthesia and Intensive Care publications
Aurora harvest

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.